Gene: CRYGD ×
Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1421
Gene Symbol: CRYGD
CRYGD 		0.100 Biomarker disease BEFREE Although rare and adult principles are applied to pediatric PCC, genetic testing plays a pivotal role in management of children, adolescents and young adults with PCC. 31246590 2019
Entrez Id: 1421
Gene Symbol: CRYGD
CRYGD 		0.100 Biomarker disease BEFREE AP = arterial phase; CECT = contrast-enhanced computed tomography; CT = computed tomography; DP = delayed phase; EVP = early venous phase; FDG = fluorodeoxyglucose; fPFMN = fractionated plasma free metanephrine; HU = Hounsfield units; MIBG = metaiodobenzylguanidine; MRI = magnetic resonance imaging; OOZ = organ of Zuckerkandl; PAE = percentage arterial enhancement; PCC = pheochromocytoma; PET = positron emission tomography; PFNMN = plasma free normetanephrine; PGL = paraganglioma; PRRT = peptide receptor radionuclide therapy; PVE = percentage venous enhancement; sPGL = sympathetic paraganglioma; UP = unenhanced phase; VMA = vanillyl mandelic acid. 30913014 2019
Entrez Id: 1421
Gene Symbol: CRYGD
CRYGD 		0.100 Biomarker disease BEFREE PCC (No-AD) was associated with a clinically meaningful and statistically significant improvement in well-being in all presenting issues. 30295211 2018
Entrez Id: 1421
Gene Symbol: CRYGD
CRYGD 		0.100 Biomarker disease BEFREE Pheochromocytomas and paragangliomas (PCCs/PGLs) are rare commonly benign neuroendocrine tumors that share pathology features and clinical behavior in many cases. 30538672 2018
Entrez Id: 1421
Gene Symbol: CRYGD
CRYGD 		0.100 Biomarker disease BEFREE We report a comprehensive molecular characterization of pheochromocytomas and paragangliomas (PCCs/PGLs), a rare tumor type. 28162975 2017
Entrez Id: 1421
Gene Symbol: CRYGD
CRYGD 		0.100 Biomarker disease BEFREE ACC = adrenal cortical carcinoma; APA = aldosterone-producing adenoma; APCC = aldosterone-producing cell cluster; CAH = congenital adrenal hyperplasia; CT = computed tomography; DOTATATE = [<sup>68</sup>Ga]-DOTA(0)-Tyr(3)-octreotate; FDG = fluorodeoxyglucose; FH = fumarate hydratase; MR = miner-alocorticoid; MDH2 = malate dehydrogenase 2; PCC = pheochromocytoma; PET = positron emission tomography; PGL = paraganglioma; SCS = subclinical cortisol-secreting; SDHB = succinate dehydrogenase subunit B; TCGA = The Cancer Genome Atlas. 28332880 2017
Entrez Id: 1421
Gene Symbol: CRYGD
CRYGD 		0.100 Biomarker disease BEFREE Pheochromocytomas and paragangliomas (PCC/PGL) are the solid tumour type most commonly associated with an inherited susceptibility syndrome. 25608029 2015
Entrez Id: 1421
Gene Symbol: CRYGD
CRYGD 		0.100 Biomarker disease BEFREE Pheochromocytomas and paragangliomas (PCCs/PGLs) are neural crest-derived tumours with a very strong genetic component. 25625332 2015
Entrez Id: 1421
Gene Symbol: CRYGD
CRYGD 		0.100 Biomarker disease BEFREE Intestinal pseudo-obstruction is a rare and relatively unknown complication of phaeochromocytoma÷ paraganglioma (PCC÷PGL). 24394736 2013
Entrez Id: 1421
Gene Symbol: CRYGD
CRYGD 		0.100 Biomarker disease BEFREE Pheochromocytomas and paragangliomas (PCC/PGL) are tumors derived from the adrenal medulla or extra-adrenal ganglia, respectively. 22429592 2012
Entrez Id: 1421
Gene Symbol: CRYGD
CRYGD 		0.100 Biomarker disease BEFREE Prediction of malignant behaviour of pheochromocytomas/sympathetic paragangliomas (PCCs/PGLs) is very difficult if not impossible on a histopathological basis. 20702724 2010